by The parenteral nutrition market is a crucial part of healthcare that provides solutions for patients with severe and long-term malnutrition and dietary deficiencies. Parenteral nutrition products deliver essential vitamins, minerals, amino acids, glucose, and lipids directly into the bloodstream, bypassing the gastrointestinal tract. It is administered via an intravenous catheter or central line.
The global parenteral nutrition market was valued US$ 4,548.7 Mn in 2023 and is expected to reach US$ 7,251 Mn by 2031 growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031.
Parenteral nutrition products are essential for people who cannot eat or cannot absorb enough nutrients through their gastrointestinal tract due to various medical conditions. It provides complete nutritional support for preterm infants, critically ill newborns and adults, and patients undergoing major surgery who cannot maintain adequate oral intake. The market has witnessed growth due to the increasing prevalence of chronic diseases and malnutrition globally. The demand for home therapy services has also fueled market expansion as parenteral nutrition can be easily administered at home with proper medical guidance and care.
Key Takeaways
Key players operating in the parenteral nutrition market are AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestlé SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.
The growing prevalence of chronic conditions like cancer and Crohn’s disease has significantly driven the Parenteral Nutrition Market Size therapies globally.
Several market players are focusing on expanding their geographical presence with new product launches and strategic collaborations with regional hospital chains and home healthcare providers, especially in emerging economies.
Market Key Trends
Rising demand for home therapy services is one of the key trends in the parenteral nutrition market. Home parenteral nutrition minimizes hospital expenses and increased patient comfort and mobility. It also provides fewer risks of hospital-acquired infections. Leading companies are developing easily portable and user-friendly parenteral nutrition formula and delivery systems specifically for home care use. Advancements in infusion technologies allowing for ambulatory and portable devices are further supporting the transition of parenteral nutrition from hospitals to home settings.
Porter’s Analysis
Threat of new entrants: The Parenteral Nutrition Companies threat of new entrants is low due to the requirement of large capital investments and time required to pass regulatory approvals.
Bargaining power of buyers: The bargaining power of buyers is high due to the availability of many alternatives in the market.
Bargaining power of suppliers: The bargaining power of suppliers is medium as there are many suppliers for raw material required for manufacturing parenteral nutrition.
Threat of new substitutes: The threat of new substitutes is medium as new innovative products are continuously being introduced by companies.
Competitive rivalry: The competitive rivalry among existing players in the parenteral nutrition market is high due to the presence of many global and domestic players.
The North America region accounted for the largest share of the global parenteral nutrition market in 2024. The availability of advanced healthcare facilities, rising incidences of chronic diseases like diabetes, cancer and malnutrition are driving the growth of the North America parenteral nutrition market.
Asia Pacific region is projected to witness the fastest growth during the forecast period from 2024 to 2031. Factors such rising geriatric population suffering from chronic diseases, increasing healthcare expenditures, growing awareness about parenteral nutritional therapies are contributing to the growth of the Asia Pacific parenteral nutrition market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Vaagisha Singh
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. LinkedIn
